Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin

URN to cite this document:: urn:nbn:de:bvb:355-epub-258360
DOI to cite this document:: 10.5283/epub.25836

Hartl, Janine ; Ott, Claudia ; Kichner, Gabriele ; Salzberger, Bernd ; Wiest, Reiner

Preview

License: Creative Commons: Attribution-Noncommercial 3.0
PDF - Published Version
(367kB)

Date of publication of this fulltext: 07 Sep 2012 06:42

Alternative links to fulltext:DOI

Details

Preview

Export bibliographical data

Abstract

Dual and triple infections with hepatitis virus C (HCV), B (HBV) and D (HDV) frequently lead to severe liver damage. Hereby we describe a 38-year-old Caucasian male coinfected with HCV (genotype 3a), HBV [positive hepatitis B surface antigen (HbsAg) and antibody to hepatitis B core antigen; negative hepatitis B e antigen (HbeAg) and antibody to hepatitis B e antigen (anti-HBe)] and HDV. ...